Sign in to confirm you’re not a bot

This helps protect our community. Learn more

Media Call: Third COVID-19 Vaccine – 2/27/2021

U.S. Food and Drug Administration

173K subscribers

From a US national health authority

Learn how experts define health sources in a journal of the National Academy of Medicine

4.7K views Streamed 4 years ago #COVID19

The FDA is scheduled to hold a media call to discuss the emergency use authorization (EUA) issued for the Janssen Biotech Inc. #COVID19 vaccine for individuals 18 years of age and older. The EUA allows the Janssen Biotech Inc. COVID-19 Vaccine to be distributed in the U.S. Acting FDA Commissioner Janet Woodcock, M.D., and Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research, will be taking questions.

...more

...more

Fda Commissioner Dr Janet Woodcock

Peter Marks

Questions and Answers

Question and Answer

Any Update in the Number of Doses That Will Be Shipped and Can You Give Us an Idea of Exactly When You Plan To Ship Doses

The Eua Label Warns against Administering the Vaccine to Anyone with a History of Severe Allergies to a Component of Johnson's Vaccine as You Mentioned Are any of the Ingredients Known by Fda To Be Allergens for Certain Individuals

Media Call: Third COVID-19 Vaccine – 2/27/2021

The FDA is scheduled to hold a media call to discuss the emergency use authorization (EUA) issued for the Janssen Biotech Inc. #COVID19 vaccine for individuals 18 years of age and older. The EUA allows the Janssen Biotech Inc. COVID-19 Vaccine to be distributed in the U.S. Acting FDA Commissioner Janet Woodcock, M.D., and Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research, will be taking questions.

Fda Commissioner Dr Janet Woodcock

Peter Marks

Questions and Answers

Question and Answer

Transcript

Follow along using the transcript.

U.S. Food and Drug Administration

173K subscribers

Live chat replay is not available for this video.